甲硝唑栓联合干扰素治疗慢性宫颈炎的临床疗效分析

麦健敏

摘要：目的：探究在慢性宫颈炎治疗中采用甲硝唑栓+干扰素的疗效。方法：将2020年3月-2021年1月在我院进行治疗的92例慢性宫颈炎患者作为此次研究对象，并在对上述患者进行随机编号、重组，划入到常规组（46例）和实验组（46例）中。在正式开展研究时，常规组患者予以甲硝唑栓治疗，而实验组则予以甲硝唑栓+干扰素治疗，最后对两组患者经相应治疗后的各项治疗进行对比分析。结果：经对比数据分析得出：实验组患者经甲硝唑栓+干扰素治疗的总有效率将常规组高，各对比数据间差异显著，即P<0.05，具有统计学意义。结论：对慢性宫颈炎患者进行治疗时，采用甲硝唑栓+干扰素的临床疗效更佳，值得在临床实践中广泛普及和应用。

关键词：甲硝唑栓;干扰素;慢性宫颈炎;联合治疗效果

Objective：To explore the efficacy of metronidazole suppository plus interferon in the treatment of chronic cervicitis. Methods： 92 cases of chronic cervicitis patients who were treated in our hospital from March 2020 to January 2021 were selected as the research objects， and the above patients were randomly numbered and recombined and divided into the conventional group （46 cases） and the experimental group （46 cases）. In the formal study， patients in the conventional group were treated with metronidazole suppository， while patients in the experimental group were treated with metronidazole suppository + interferon. Finally， the treatment of the two groups were compared and analyzed. Results： through comparative data analysis， the total effective rate of the experimental group was higher than that of the conventional group， the difference between the comparative data was significant， that is， P < 0.05， with statistical significance. Conclusion： metronidazole suppository plus interferon has better clinical effect in the treatment of chronic cervicitis， which is worthy of wide popularization and application in clinical practice.

[Key words]metronidazole suppository; Interferon; Chronic cervicitis; Combined treatment effect

慢性宫颈炎是临床上较为常见的妇科疾病，主要出现在经产妇女中，多表现为白带异常[1-2]。目前，在对该疾病进行治疗时，主要采用甲硝唑栓治疗，但是该药物治疗后的效果难达预期。有研究人员提出，采用甲硝唑栓+干扰素的方式进行联合治疗，可大大增强治疗效果[3]。特此，本文针对甲硝唑栓联合干扰素治疗慢性宫颈炎的临床疗效展开研究，并做出如下报告：

1 资料与方法

1.1 一般资料

参与本次研究的92例患者均为2020年3月-2021年1月在我院接受治疗的慢性宫颈炎患者，各患者均知晓本次研究内容，已签署意愿书。在开展研究时，将上述患者进行随机编号、重组，划入到常规组（46例）和实验组（46例）中。……